Académique Documents
Professionnel Documents
Culture Documents
By Simon Readhead QC
High expectations are the key to everything. Samuel Moore Walton was
explaining how he built Wal-Mart from a single store in Rogers, Arkansas in
1962 into the worlds largest retailer but his observation also applies to
damages in personal injury cases where a high life expectation will
significantly increase the size of the award. Life expectancy is less
important (but not redundant) where periodical payments are available to
meet part of the claim for future loss, usually care and case management.
However, in most personal injury cases and particularly when assessing
general damages and other heads of loss including accommodation, life
expectancy and the appropriate life multiplier remain very important. The
argument often advanced is that lawyers and judges frequently over
estimate both by ignoring or misunderstanding the relevant statistics.
In Royal Victoria Infirmary (RVI) NHS Trust v B (A Child) [2002] EWCA Civ
348; [2002] PIQR Q10 the judge based his decision as to the Claimants life
expectancy partly on the medical evidence and partly on statistical
evidence from Professor Strauss, Emeritus Professor of Statistics at the
University of California.
The Court of Appeal considered the role of such statistical evidence. In the
view of Tuckey L.J. it was wrong to say that the court should not have
regard to relevant statistical evidence but it was also wrong to decide
expectation of life purely by reference tostatistics. In an appropriate
case statistical evidence may well provide a useful starting point for the
judge.
In Arden v Malcolm [2007] EWHC 404 (QBD) the Claimant suffered traumatic
brain injuries following a motor cycle accident. Tugendhat J. refused the
Defendant insurers permission to rely on evidence from Professor Strauss in
relation to life expectation because the clinician experts should be the
normal and primary route through which such statistical evidence should be
put before the court. It is only if there is disagreement between them on a
statistical matter that the evidence of a statistician .ought normally to
be required.
The publication of the 6th edition of the Ogden Tables on the 3 rd May 2007
seemed to offer further hope to the statisticians. This time the focus of
attention was the multiplier in cases where a Claimants life expectancy has
been reduced. Paragraph 20 of the Explanatory Notes (P20EN) to the Ogden
Tables specifically warns against using Table 28 to ascertain a reduced life
multiplier as this is likely to give a multiplier which is too high since this
approach does not allow for the distribution of deaths around the expected
length of life. For a group of similarly impaired lives of the same age, some
will die before the average life expectancy and some after; allowing for
this spread of deaths results in a lower multiplier than assuming payment
for a term certain equal to the life expectancy. Thus for a male with a 20
year life expectancy the formula suggested in P20EN (which is based on the
0% column in Table 1) produces a multiplier of 15.08 compared to 15.78 for
a term certain of 20 years using the 2.5% column in Table 28. In a case in
which annual care costs are assessed at 150,000 this is a difference of
105,000.
Simon Readhead QC
Barrister
www.1chancerylane.com